Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. (Record no. 24441644)

MARC details
000 -LEADER
fixed length control field 02435 a2200661 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517005500.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201503s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1527-7755
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1200/JCO.2013.54.3298
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cainap, Calin
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150316
245 00 - TITLE STATEMENT
Title Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Date of publication, distribution, etc. Jan 2015
300 ## - PHYSICAL DESCRIPTION
Extent 172-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Hepatocellular
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hand-Foot Syndrome
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypertension
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Niacinamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Odds Ratio
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenylurea Compounds
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor Protein-Tyrosine Kinases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sorafenib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Qin, Shukui
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Wen-Tsung
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chung, Ik Joo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pan, Hongming
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cheng, Ying
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kudo, Masatoshi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kang, Yoon-Koo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Pei-Jer
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Toh, Han-Chong
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gorbunova, Vera
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eskens, Ferry A L M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Qian, Jiang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McKee, Mark D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ricker, Justin L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Carlson, Dawn M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name El-Nowiem, Saied
773 0# - HOST ITEM ENTRY
Title Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Related parts vol. 33
-- no. 2
-- p. 172-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1200/JCO.2013.54.3298">https://doi.org/10.1200/JCO.2013.54.3298</a>
Public note Available from publisher's website

No items available.